ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Doconexent

HCID 445580
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
6217-54-5
標準SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O
InChIKey
MBMBGCFOFBJSGT-KUBAVDMBSA-N
分子式
C22H32O2
平均分子量
328.5 g/mol
単同位体質量
328.24023026

概要

All-cis-docosa-4,7,10,13,16,19-hexaenoic acid is a docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. It has a role as an antineoplastic agent, a nutraceutical, a mouse metabolite, a human metabolite, a Daphnia tenebrosa metabolite and an algal metabolite. It is an omega-3 fatty acid and a docosahexaenoic acid. It is a conjugate acid of a (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate.

名称と識別子

優先名称
Doconexent
IUPAC
(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid

名称と別名

DoconexentDoconexentoDoconexentumDoxonexentAquaGrow AdvantageMartek DHA HMRopufa 60Monolife 50CCRIS 7670UNII-ZAD9OKH9JCZAD9OKH9JCDoconexentum [INN-Latin]
名称をさらに表示
Doconexento [INN-Spanish]C22:6 (n-3)22:6 n-3CHEBI:28125Doconexentum (INN-Latin)Doconexento (INN-Spanish)Complete Natal DHAWesNatal DHA Complete

データベース識別子

CAS
6217-54-5
PubChem CID
445580
DTXSID
DTXSID5040465
ChEMBL
CHEMBL367149
ChEBI
CHEBI:28125
UNII
ZAD9OKH9JC
EC Number
612-950-9
Nikkaji
J381.483A

物性

構造計算による物性補完中

XLogP
6.2
極性表面積
37.3 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
14
重原子数
24
形式電荷
0
複雑度
462

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
Lipids · 2 件

Lipids -> Unambiguous Lipids

Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Unsaturated fatty acids [FA0103]

SpringerMaterials PropertiesChemical diffusion
Physical DescriptionLiquid
Collision Cross Section · 3 件

187.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Sample Type: Human bronchoalveolar lavage fluid (BALF); Dataset: Unambiguous Lipids]

184.62 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]

183.9 Ų [M+Na]+

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory Information4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

化学と産業

薬理情報

Pharmacodynamics · 1 件

DHA in the central nervous system is found in the phospholipid bilayers where it modulates the physical environment and increase the free volume within the membrane bilayer. It influences the G-protein coupled receptor activity and affects transmembrane transport and cell interaction with the exterior world. It is also reported to promote apoptosis, neuronal differentiation and ion channel activity. Like other polyunsaturated fatty acids, DHA acts as a ligand at PPARs that plays an anti-inflammatory effect and regulate inflammatory gene expression and NFκB activation. DHA also gives rise to resolvins and related compounds (e.g., protectins) through pathways involving cyclooxygenase and lipoxygenase enzymes to resolve the inflammatory responses.

Mechanism of Action · 1 件

DHA and its conversion to other lipid signalling moleccules compete with the arachidonic acid cascade from endogenous phospholipids and shift the inflammatory state to being more anti-inflammatory. DHA inhibits endotoxin-stimulated production of IL-6 and IL-8 in human endothelial cells. Derivatives of DHA are anti-inflammatory lipid mediators. Lipid mediators resolvin D1 and protectin D1 all inhibit transendothelial migration of neutrophils, so preventing neutrophilic infiltration at sites of inflammation, resolvin D1 inhibits IL-1β production, and protectin D1 inhibits TNF and IL-1β production. Monoxydroxy derivative of DHA converted by LOX inhibit thromboxane-induced platelet aggregation. DHA supplementation has also shown to reduce the levels of serum C-reactive protein (CRP) and other circulating markers of inflammation such as neutrophils in hypertriglyceridemic men. DHA acts as a ligand at peroxisome proliferator-activated receptor (PPAR) gamma and alpha that regulate lipid signalling molecule-mediated transduction pathways and modulate inflammation. As a natural ligand, DHA induces a protective effect in retinal tissues by activating retinoid x receptors and subsequent ERK/MAPK signaling pathway in photoreceptors to promote their survival and differentiation, stimulating the expression of antiapoptotic proteins such as Bcl-2 and preserving mitochondrial membrane potential.

Biological Half-LifeApproximately 20 hours.
Metabolism/Metabolites · 1 件

関連反応

38 件
反応記録を作成
HRID 28304 の反応式
HRID 28304反応物として
HRID 85402 の反応式
HRID 85402反応物として
HRID 85405 の反応式
HRID 85405反応物として
HRID 339286 の反応式
HRID 339286反応物として
HRID 339291 の反応式
HRID 339291反応物として
HRID 573396 の反応式
HRID 573396反応物として
HRID 573397 の反応式
HRID 573397反応物として
HRID 591103 の反応式
HRID 591103反応物として
前へ1 / 5 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

DHA can be metabolized into DHA-derived specialized pro-resolving mediators (SPMs), DHA epoxides, electrophilic oxo-derivatives (EFOX) of DHA, neuroprostanes, ethanolamines, acylglycerols, docosahexaenoyl amides of amino acids or neurotransmitters, and branched DHA esters of hydroxy fatty acids, among others. It is converted to 17-hydroperoxy-DHA derivatives via COX-2 and 15-LOX and 5-LOX activity. These derivatives are further converted into D-series resolvins and protectins with potent anti-inflammatory potential and potent neuroprotective effect. DHA may also be metabolized to 19,20-epoxydocosapentaenoic acids (EDPs) and isomers via CYP2C9 activity. Epoxy metabolites are reported to mediate anti-tumor activity by inhibiting angiogenesis, tumor growth, and metastasis.

Absorption, Distribution and Excretion · 2 件

Like other omega-3 fatty acids, DHA is hydrolyzed from the intestines and delivered through the lymphatic circulation. Plasma DHA concentrations increase in a dose-dependent and saturable manner.

DHA is the most abundant n−3 fatty acid in membranes and is present in all organs. It is also the most variable among organs and is particularly abundant in neural tissue, such as brain and retina, where it is several hundred-fold more abundant than EPA.

Tissue LocationsAdipose Tissue
Cellular LocationsCytoplasm
Metabolite Pathwaysalpha-Linolenic acid metabolism

用途と製造

UsesUse (kg; approx.) in Germany (2009): ?5000